Engineering Polymer Systems for Improved Drug Delivery

Table of Contents:
FOREWORD xi PREFACE xiii CONTRIBUTORS xv PART I INTRODUCTION 1 1 FUNDAMENTALS OF DRUG DELIVERY 3 Rebecca A. Bader 1.1 Introduction: History and Future of Drug Delivery 3 1.2 Terminology 5 1.3 Basic Pharmacokinetics 8 1.4 Basic Pharmacodynamics 12 1.5 Mass Transfer 13 1.6 Key Points 23 1.7 Homework Problems 23 2 CHALLENGES OF DRUG DELIVERY 29 Patricia R. Wardwell and Rebecca A. Bader 2.1 Introduction 29 2.2 History and Challenges of Drug Delivery 30 2.3 Physical Barriers 31 2.4 Metabolic and Chemical Concerns 39 2.5 Physical Properties of Therapeutics 42 2.6 Polymer Carriers as a Solution to Challenges 45 2.7 Key Points 50 2.8 Homework Problems 50 PART II INJECTABLE POLYMERIC DRUG DELIVERY SYSTEMS 55 3 POLYMER–DRUG CONJUGATES 57 Cristina Fante and Francesca Greco 3.1 Introduction 57 3.2 Historical Perspective 58 3.3 Polymer–Drug Conjugates: Biological Rationale 59 3.4 Structural Features of Polymer–Drug Conjugates 62 3.5 Making a Polymer–Drug Conjugate 68 3.6 Current Challenges and Future Perspectives 71 3.7 Key Points 75 3.8 Worked Example 76 3.9 Homework Problems 76 4 POLYMERIC MICROPARTICLES 85 Noelle K. Comolli and Colleen E. Clark 4.1 Introduction 85 4.2 The Rationale for Microparticles 86 4.3 Defining the Design Criteria 87 4.4 Polymer Selection 89 4.5 Microparticle Synthesis 91 4.6 Microparticle Characterization Methods 96 4.7 Drug Release from Microparticles 100 4.8 Microparticle Design Examples 108 4.9 Key Points 110 4.10 Worked Example 110 4.11 Homework Problems 111 5 POLYMERIC NANOPARTICLES 117 Andrew L. Vasilakes, Thomas D. Dziubla, and Paritosh P. Wattamwar 5.1 Introduction 117 5.2 PNP Design 124 5.3 PNP Formulation Methods and Targeting 128 5.4 Nanoparticle Targeting Overview 133 5.5 PNP Characterization 139 5.6 Major Clinical Achievements 147 5.7 Key Points 148 5.8 Worked Example 149 5.9 Homework Problems 150 6 BLOCK COPOLYMER MICELLES AND VESICLES FOR DRUG DELIVERY 163 James D. Robertson, Nisa Patikarnmonthon, Adrian S. Joseph, and Giuseppe Battaglia 6.1 Introduction 163 6.2 Drug Encapsulation and Release 165 6.3 Bioavailability and Biodistribution 166 6.4 Stimuli Responsiveness 170 6.5 The Immune System 174 6.6 Gene Therapy 177 6.7 Cancer Therapy 180 6.8 Conclusions 182 6.9 Key Points 182 6.10 Homework Problems 183 PART III IMPLANTABLE POLYMERIC DRUG DELIVERY SYSTEMS 189 7 IMPLANTABLE DRUG DELIVERY SYSTEMS 191 Luis Solorio, Angela Carlson, Haoyan Zhou, and Agata A. Exner 7.1 Introduction 191 7.2 Nondegradable Polymeric Implants 193 7.3 Biodegradable Polymeric Implants 198 7.4 Conclusions and Future Perspectives 215 7.5 Key Points 216 7.6 Homework Problems 216 8 POLYMERIC DRUG DELIVERY SYSTEMS IN TISSUE ENGINEERING 227 Matthew Skiles and James Blanchette 8.1 Introduction 227 8.2 Wound Healing as a Prototype for Adult Tissue Generation 228 8.3 Bioactive Factors in Tissue Engineering and Regenerative Medicine 232 8.4 Delivery of Growth Factors in Tissue Engineering and Regenerative Medicine 248 8.5 Key Points 268 8.6 Worked Example 269 8.7 Homework Problems 270 PART IV ORAL POLYMERIC DRUG DELIVERY SYSTEMS 283 9 ORAL CONTROLLED-RELEASE POLYMERIC DRUG DELIVERY SYSTEMS 285 James W. McGinity, James C. DiNunzio, and Justin M. Keen 9.1 Introduction 285 9.2 Release Mechanisms of Oral Polymeric Dosage Forms 288 9.3 Oral Polymeric Release Modifiers 295 9.4 Manufacturing Technologies and Industrial Applications of Controlled Release 297 9.5 Worked Example 311 9.6 Key Points 314 9.7 Homework Problems 314 10 MUCOADHESIVE DRUG DELIVERY SYSTEMS 319 Srinath Muppalaneni, David Mastropietro, and Hossein Omidian 10.1 Introduction 319 10.2 Factors Affecting Mucoadhesion 320 10.3 Polymer–Mucus Interactions 320 10.4 Mucoadhesion Mechanisms 322 10.5 Mucoadhesive Polymers 324 10.6 Novel Mucoadhesive Materials 327 10.7 Mucoadhesion Testing 330 10.8 Drug Release Studies 332 10.9 Mucoadhesive Dosage Forms 332 10.10 Conclusion 334 10.11 Key Points 334 10.12 Homework Questions 337 11 ENHANCED ORAL DRUG DELIVERY THROUGH METABOLIC PATHWAYS 343 Gregory Russell-Jones 11.1 Introduction 343 11.2 Uptake of Nutrients from the Intestine 344 11.3 Nutrient Transport in the Intestine 349 11.4 Use of Nutrient Transporters for Drug Delivery 352 11.5 Case Study: The Use of the Vitamin B2 Uptake System for Drug Delivery 352 11.6 Key Points 365 11.7 Worked Example 365 11.8 Homework Problems 366 PART V ADVANCED POLYMERIC DRUG DELIVERY 375 12 STIMULI-RESPONSIVE POLYMER DELIVERY SYSTEMS 377 Amy Van Hove, Zhanwu Cui, and Danielle S.W. Benoit 12.1 Introduction 377 12.2 Temperature-Responsive Polymers for Drug Delivery 378 12.3 pH-Responsive Polymers for Drug Delivery 387 12.4 Reduction/Oxidation (Redox)-Responsive Polymers 397 12.5 Enzymatically Responsive Drug Delivery 403 12.6 Key Points 415 12.7 Homework Questions 416 13 AFFINITY-BASED DRUG DELIVERY 429 Andrew S. Fu and Horst A. von Recum 13.1 Introduction 429 13.2 Association Constant 430 13.3 Worked Example 432 13.4 Affinity-Based Drug Delivery Systems 437 13.5 Mathematical Modeling of Affinity-Based Systems 444 13.6 Challenges and Future Directions 448 13.7 Key Points 448 13.8 Homework Problems 449 INDEX 453

About the Author :
REBECCA A. BADER, PhD, is Assistant Professor in the Department of Biomedical & Chemical Engineering at Syracuse University and resident member of the Syracuse Biomaterials Institute. Combining her expertise in chemistry and materials science, Dr. Bader's current research focuses on the development of polysaccharide-based carrier systems for targeted delivery in the treatment of rheumatoid arthritis, biofilm-related diseases, cancer, and vascular diseases. DAVID A. PUTNAM, PhD, is Associate Professor in the College of Engineering at Cornell University. His research is dedicated to the rational design and synthesis of functional biomaterials to facilitate targeted and controlled drug delivery. Dr. Putnam is a Fellow of the Coulter Foundation and the American Institute for Medical and Biological Engineering, an honor bestowed upon the top 2% of biomedical engineers in the United States.